Literature DB >> 18708147

Recombinant human SMOCs produced by in vitro refolding: calcium-binding properties and interactions with serum proteins.

Marko Novinec1, Lidija Kovacic, Nives Skrlj, Vito Turk, Brigita Lenarcic.   

Abstract

Secreted modular calcium-binding (SMOC) proteins are little known members of the BM-40 family of matricellular proteins. SMOC-1 is localized in basement membranes, while SMOC-2 exhibits pro-angiogenic properties and stimulates cell cycle progression via integrin-linked kinase. In this work we have expressed recombinant human SMOCs in inclusion bodies in Escherichia coli. Soluble proteins were prepared by in vitro refolding with a final yield of approximately 3mg of purified SMOCs per liter of bacterial culture. The folding state of the products and their ability to reversibly bind calcium ions were verified by CD spectroscopy. The EF hands of the refolded SMOCs were both functional, one had high affinity for calcium ions (K(d) values in the 0.7-1 microM range), while the other had lower affinity (K(d) values 20-25 microM). The proteins were also examined for their ability to bind blood serum proteins. Three of the bands specifically retained on SMOC-Sepharose were identified as C-reactive protein, an acute phase protein from the pentraxin family, the basement membrane and elastic fiber-associated fibulin-1, and vitronectin, which is involved in cell adhesion, migration and proliferation and binds numerous extracellular and membrane proteins, including integrins. The interactions were additionally confirmed in solution using purified individual proteins by the method of biotin label transfer from one interacting partner to the other. Their identification is among the first pieces of information about the action of the SMOCs on molecular level and opens new possibilities for future research aimed towards elucidating the physiological roles of these versatile proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708147     DOI: 10.1016/j.pep.2008.07.009

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

Review 1.  Diverse biological functions of the SPARC family of proteins.

Authors:  Amy D Bradshaw
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

2.  Mutations in the SPARC-related modular calcium-binding protein 1 gene, SMOC1, cause waardenburg anophthalmia syndrome.

Authors:  Hana Abouzeid; Gaëlle Boisset; Tatiana Favez; Mohamed Youssef; Iman Marzouk; Nihal Shakankiry; Nader Bayoumi; Patrick Descombes; Céline Agosti; Francis L Munier; Daniel F Schorderet
Journal:  Am J Hum Genet       Date:  2010-12-30       Impact factor: 11.025

3.  Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.

Authors:  A Shvab; G Haase; A Ben-Shmuel; N Gavert; T Brabletz; S Dedhar; A Ben-Ze'ev
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

4.  The heparin-binding activity of secreted modular calcium-binding protein 1 (SMOC-1) modulates its cell adhesion properties.

Authors:  Marina Klemenčič; Marko Novinec; Silke Maier; Ursula Hartmann; Brigita Lenarčič
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

5.  SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR.

Authors:  J Terrig Thomas; Lina Chhuy-Hy; Kristin R Andrykovich; Malcolm Moos
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

6.  SMOC can act as both an antagonist and an expander of BMP signaling.

Authors:  J Terrig Thomas; D Eric Dollins; Kristin R Andrykovich; Tehyen Chu; Brian G Stultz; Deborah A Hursh; Malcolm Moos
Journal:  Elife       Date:  2017-03-21       Impact factor: 8.140

Review 7.  Secreted modular calcium-binding proteins in pathophysiological processes and embryonic development.

Authors:  Qiang Gao; Hsiao-Pei Mok; Jian Zhuang
Journal:  Chin Med J (Engl)       Date:  2019-10-20       Impact factor: 2.628

8.  SMOC2 inhibits calcification of osteoprogenitor and endothelial cells.

Authors:  Tine Peeters; Silvia Monteagudo; Przemko Tylzanowski; Frank P Luyten; Rik Lories; Frédéric Cailotto
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.